Pharmacogenetics and Variability In Drug Exposure and Clinical

Recruiting

1 years or below

All

Phase N/A

150 participants needed

1 Location

Brief description of study

This observational study will follow infants born with a gestational age of less than 32 weeks requiring positive pressure ventilation and planned clinical treatment with corticosteroids for bronchopulmonary dysplasia.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: bronchopulmonary dysplasia,BPD
Age: 1 years or below
Gender: All

Infants less than 32 weeks at birth Infants treated with corticosteroids for BPD (per neonatal attending clinical discretion) Receiving positive pressure ventilation (NIV, CPAP or endotracheal tube mediated assisted ventilation) Less than 14 days of age, <180 days of age

Updated on 04 Aug 2024. Study ID: 844677

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Pharmacogenetics and Variability In Drug Exposure and Clinical Response to Corticosteroids in Severe BPD

Brief description of study

Eligibility of study

Find a site

Interested in the study